Table 1.
No. | Ref. | Age (yr) | Sex | Histology | Location | Maximal dimension (cm) | Treatment | Follow-up information | Other findings |
1 | Sabanathan et al[2] | 67 | M | SCNEC | Bm | 5 | Palliative bypass and chemotherapy | Alive 6 mo | |
2 | Miyashita et al[3] | 85 | F | SCNEC | Bi | 3 | Palliative bypass | DOD 5 mo after surgery | |
3 | Kuraoka et al[4] | 75 | M | SCNEC | Bi | 4.5 | Resection | Alive 5 mo after surgery | Dysplasia |
4 | Hazama et al[5] | 60 | M | SCNEC | CBD | 0.3 | Neoadjuvant chemotherapy and resection | DOD 12 mo after surgery | |
5 | Arakura et al[6] | 70 | F | SCNEC | Bm | 3 | Resection and chemotherapy | DOD 14 mo after surgery | |
6 | Park et al[7] | 60 | F | SCNEC | Bs-Bm | 3 | Resection | DOD 5 mo after surgery | |
7 | Thomas et al[8] | 54 | M | SCNEC | Bh-CBD | NA | Resection | Alive With Metastasis, 6 mo | Clonorchis sinensis infestation |
8 | Viana Miguel et al[9] | 76 | M | SCNEC | Bm | NA | Resection, chemotherapy and irradiation | Alive 5 mo after surgery | Gallstone |
9 | Jeon et al[10] | 65 | M | SCNEC | Bs-Bm | 2 | Presection and chemotherapy | DOD 12 mo after surgery | |
10 | Nakai et al[11] | 32 | M | SCNEC | CBD | NA | NA, diagnosed by autopsy | NA | |
11 | Arakura et al[12] | 75 | M | SCNEC | Bh, Bs, Bm, Bi | 6.5 | Chemotherapy and irradiation | DOD 10 mo after therapy | |
12 | Hosonuma et al[13] | 69 | F | SCNEC | Bs-Bm | 3 | Biliary drainage | Alive 2 mo after biliary drainage | |
13 | Okamura et al[14] | 62 | M | SCNEC | Bm | 3 | Preoperative chemotherapy, resection and irradiation | DOD 20 mo after surgery | |
14 | Yamaguchi et al[15] | 77 | F | NEC | Bi | NA | Resection and chemotherapy | Alive 27 mo | |
15 | van der Wal et al[16] | 55 | M | SCNEC + atypical carcinoid + AD | Bm | 4 | Resection | NA | Dysplasia/carcinoma in situ |
16 | Nishihara et al[17] | 64 | M | SCNEC + AD | Bh-Bs | 1.9 | Resection | Alive 8 mo after surgery | |
17 | Yamamoto et al[18] | 71 | F | SCNEC + AD | Bh | 6 | Resection | DOD 7 mo after surgery | Common bile duct stones |
18 | Kim et al[19] | 64 | M | SCNEC + AD | Bm | 3 | Resection | Alive 30 d after surgery | Clonorchis sinensis infestation |
19 | Edakuni et al[20] | 82 | F | SCNEC + AD | Bm | 6 | Resection | Alive 45 mo after surgery | |
20 | Kaiho et al[21] | 66 | F | SCNEC + AD | Bm | 3.5 | Resection and chemotherapy | DOD 8 mo after surgery | |
21 | Sato et al[22] | 68 | M | LCNEC + AD | Bi | 2 | Resection and chemotherapy | DOD 3 mo after surgery | |
22 | Demoreuil et al[23] | 73 | M | LCNEC + AD | Bh-Bs | 3 | Resection and chemotherapy | DOD 12 mo after surgery | |
23 | Current report, 2013 | 76 | M | LCNEC | Bh-Bs | 5 | Resection | DOD 21 d after surgery | Dysplasia, intestinal type |
SCNEC: Small cell neuroendocrine carcinoma; NEC: Nneuroendocrine carcinoma, not otherwise specified; AD: Adenocarcinoma; LCNEC: Large cell neuroendocrine carcinoma; Bm: Mid portion of common bile duct; Bi: Inferior or distal common bile duct; CBD: Common bile duct, not otherwise specified; Bs; Superior or proximal common bile/hepatic duct; Bh: Hilar bile duct; DOD: Died of disease. N/A: Information not available; F: Female; M: Male.